“While the jury’s $130 million verdict is significant and may sound large in the abstract, it may not be enough without enhancement to deter infringing conduct given the context of this case,” Judge Olguin wrote. Evidence presented at trial shows that the infringing products sold by Cochlear generated $1.8 billion in revenues. Cochlear had publicly stated in a 2016 annual report that the jury’s verdict won’t disrupt Cochlear’s business or U.S. customers.
The post Judge Awards Enhancement of Damages to $268 Million in Cochlear Implant Patent Case appeared first on IPWatchdog.com | Patents & Patent Law.
Judge Awards Enhancement of Damages to $268 Million in Cochlear Implant Patent Case
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- USPTO Precedential Opinion Panel Delivers Key Ruling for Inventors
- Key Points from Responses to Senator Hirono’s Questions to Section 101 Panelists
- As Stakeholders Await New 101 Bill, Responses to Tillis Underscore Need for Movement
- Federal Circuit Agrees That Argument-Based Prosecution Estoppel Barred Amgen from Succeeding on Infringement Claim
- Note to President Trump: Silicon Valley Pirates Are a Bigger Threat to Intellectual Property Than China
Recent Posts
- USPTO Precedential Opinion Panel Delivers Key Ruling for Inventors
- Key Points from Responses to Senator Hirono’s Questions to Section 101 Panelists
- As Stakeholders Await New 101 Bill, Responses to Tillis Underscore Need for Movement
- Creating a Home(work) Station That Gets Top Marks
- Federal Circuit Agrees That Argument-Based Prosecution Estoppel Barred Amgen from Succeeding on Infringement Claim